Jennison Associates’s Decoy Therapeutics DCOY Stock Holding History

Jennison Associates’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Hold	0	–	-$1.73M	–	775
2016 Q4	–	Sell	-1	Closed	-$6.1M	–	564
2016 Q3	$7.99M	Hold	1	–	–	0.01%	488
2016 Q2	$7.05M	Hold	1	–	–	0.01%	487
2016 Q1	$7.57M	Hold	1	–	–	0.01%	471
2015 Q4	$8.18M	Hold	1	–	–	0.01%	494
2015 Q3	$7.89M	Hold	1	–	–	0.01%	520
2015 Q2	$12.4M	Hold	1	–	–	0.01%	502
2015 Q1	$14.6M	Buy	+1	New	+$15.5M	0.01%	472

Other funds holding DCOY

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Jennison Associates's DCOY Position: Q1 2017 in Review

Jennison Associates held its Decoy Therapeutics (DCOY) position steady in Q1 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #775.

Jennison Associates first reported a position in DCOY in Q1 2015 and has held it in 7 quarters since. The position peaked at $14.6M in Q1 2015. 3 funds tracked by Wall St. Rank hold DCOY as of Q1 2017.

Jennison Associates held 0 shares of Decoy Therapeutics worth $0 as of Q1 2017.
Jennison Associates left its Decoy Therapeutics share count unchanged in Q1 2017.
Decoy Therapeutics made up ﹤0.01% of Jennison Associates's portfolio in Q1 2017, its #775 holding.
Jennison Associates first reported a position in Decoy Therapeutics in Q1 2015 and has held it in 7 quarters since.
Jennison Associates's Decoy Therapeutics position peaked at $14.6M in Q1 2015.
3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q1 2017.

Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.